Figure 4From: Pharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib Correlation of tumor shrinkage with the worst grade of toxicity. Correlation analyses were performed for maximum tumor shrinkage percentage change from baseline and the worst grade of hypertension (A), proteinuria (B), and fatigue (C) over the treatment duration. The correlation coefficient (r) and P value for each analysis is indicated.Back to article page